Sign in
Taking peopleNo phase

Spinal cord stimulation and rehabilitation for people with long-term paralysis from spinal cord injury

Tests an implanted spinal stimulator with rehabilitation in adults with chronic spinal cord injury.

Key facts

Who runs it
University of Sao Paulo General Hospital
Where
Brazil1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Epidural Electrical Stimulation to Restore Standing and Walking in Patients With Chronic Paralysis Due to Spinal Cord Injury: A Study on Motor Recovery, Spasticity Reduction, and Quality of Life Improvement Through Neuromodulation and Intensive Rehabilitation
Status
Recruiting
People taking part
10 people, planned
Started
28 Jan 2022
Expected to end
10 Jan 2027
Type of study
Interventional
Treatments tested
  • Epidural Electrical Stimulation (EES) using an implanted paddle lead and pulse generator combined with a 12-month intensive rehabilitation program.
Record updated
26 February 2025

Who can take part

The trial is looking for adults with long-lasting paralysis from a spinal cord injury who cannot stand or walk. They will get an implanted spinal cord stimulator and intensive rehabilitation.

Age
18 to 50 years
Sex
All sexes
Disease stage
Stable spinal cord injury at least 6 months after the injury. ASIA A or B, with inability to stand or walk. Injury between C7 and T10. Reflexes below the injury level must still work.
Earlier treatment
Cannot join if you had Botulinum toxin injections in the past 6 months. Cannot join if you now use electronic devices such as baclofen pumps or cardiac pacemakers.
Biomarker or test result
No voluntary leg movements on EMG (muscle electrical) testing. MRI must not show a complete cut of the spinal cord, major shrinking of the cord, or major syringomyelia (fluid cavity in the cord).
Main reasons for not taking part
  • Health problems that raise surgery risk, such as blood thinner use or heart and lung problems
  • Severe autonomic problems, or past stroke or heart attack linked to autonomic dysreflexia
  • Uncontrolled pain, severe spasticity, unhealed spine fractures, pressure ulcers or active infection
  • Suspected misuse of opioids, alcohol or illegal drugs, or significant mental health disorders
  • Pregnancy, or expected life of less than 2 years
Show the full registry criteria (23)Hide the full registry criteria

Who can take part

  • Adult patients aged 18 to 50 years
  • Stable spinal cord injury (SCI) at least 6 months post-injury
  • Classified as ASIA A or B with inability to stand or walk
  • Injury located between C7 and T10
  • Intact segmental reflexes below the level of injury
  • Ability to understand and sign the informed consent form
  • Willingness and capability to attend daily physiotherapy sessions
  • Clinically stable overall health as determined by the investigators

Who cannot take part

  • Presence of comorbidities that increase surgical risk (e.g., anticoagulation therapy, cardiopulmonary issues)
  • Estimated life expectancy of less than 2 years due to severe concomitant malignant or clinical conditions
  • Botulinum toxin injections received in the past 6 months
  • Current use of electronic devices such as baclofen pumps or cardiac pacemakers
  • Locomotor deformities or additional neurological disorders that may compromise evaluation
  • Significant dysautonomia or history of stroke or myocardial infarction associated with autonomic dysreflexia
  • Uncontrolled pain, severe spasticity, or other conditions that hinder rehabilitation participation
  • Clinically significant mental health disorders
  • Active infection
  • MRI evidence of complete spinal cord transection, significant spinal atrophy, or significant syringomyelia
  • Suspected abuse of opioids, alcohol, or other illegal substances
  • Presence of voluntary movements during EMG testing in the lower extremities
  • Unhealed vertebral fractures
  • Presence of pressure ulcers
  • Pregnancy

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Spinal cord injuries

This trial is currently available in Brazil.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Spinal cord injury (SCI) is a major cause of morbidity and disability worldwide, significantly impacting patients' quality of life and functional independence. Despite advances in rehabilitation therapies, many individuals with SCI remain unable to stand or walk. Epidural electrical stimulation (EES) has emerged as a promising neuromodulation therapy to restore motor function in individuals with chronic paralysis.

Read full original descriptionShow less

This prospective clinical study aims to evaluate the efficacy and safety of EES in patients with chronic SCI who have lost the ability to stand or walk. The primary objective is to assess late-stage gait recovery following the implantation of an epidural spinal cord stimulator, using validated clinical scales such as the Fugl-Meyer Assessment - Lower Extremity (FMA-LE) and BMCA VRI.

Secondary objectives include evaluating:

The ability to stand independently (measured by the Berg Balance Scale). Improvements in walking capacity, with or without assistance. Changes in spasticity induced by EES (Modified Ashworth Scale). Reduction in pain perception (DN4, Brief Pain Inventory [BPI], Pain Disability Index [PDI]).

Improvements in neurogenic bladder and bowel dysfunction (NBSS and NBDS). Enhancements in quality of life (SCI-QOL, WHOQOL-BREF) and mood (Beck Depression Inventory [BDI]).

The study will recruit 10 adult patients (ages 18-50) with chronic, stable SCI (≥6 months post-injury) classified as ASIA A or B, with lesions between C7 and T10 and intact segmental reflexes below the injury level. Participants will undergo an intensive 3-month pre-implant rehabilitation program to maximize their baseline motor potential.

Following this period, eligible patients will receive surgical implantation of an epidural spinal cord stimulator (Medtronic Specify 5-6-5 paddle lead and Intellis pulse generator). After a 1-month post-surgical recovery period, patients will engage in a 12-month intensive rehabilitation protocol (5 supervised sessions per week), with the stimulator activated to facilitate motor recovery.

Patients will be assessed monthly through clinical evaluations and surface electromyography (EMG) to measure motor control improvements. Outcomes will be compared before and after EES implantation to determine the effectiveness of the intervention.

This study seeks to provide further evidence on the potential of epidural electrical stimulation in restoring standing and walking abilities in individuals with SCI. If successful, it could contribute to expanding treatment options for patients with chronic paralysis.

The group in the trial

  • Epidural Electrical Stimulation + Intensive Rehabilitation ArmTreatment being tested

    Patients enrolled in this arm will undergo surgical implantation of an epidural spinal cord stimulator (Medtronic Specify 5-6-5 paddle lead and Intellis pulse generator) followed by a 12-month intensive rehabilitation program. After a one-month post-operative recovery period, electrical stimulation will be activated during five supervised physiotherapy sessions per week. The intervention combines neuromodulation with targeted motor and balance exercises to facilitate gait recovery, reduce spasticity, alleviate pain, and enhance overall quality of life. Outcomes will be monitored through clinical scales, surface electromyography, and video documentation, with patients serving as their own controls by comparing pre- and post-implantation performance.

    Treatment: Epidural Electrical Stimulation (EES) using an implanted paddle lead and pulse generator combined with a 12-month intensive rehabilitation program.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Epidural Electrical Stimulation for Motor and Functional Recovery in Patients With Chronic Paralysis Due to Spinal Cord Injury: A Prospective Study Evaluating Gait Restoration, Spasticity Reduction, Pain Management, and Quality of Life Improvements Through Neuromodulation and Intensive Rehabilitation
Plain-language title
Spinal cord stimulation and rehabilitation for people with long-term paralysis from spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT06847295, who can take part
Publications
Record updated
26 February 2025